The global Drugs Of Abuse Testing Market is expected to grow at a CAGR of 5.33% over the forecast period from 2019 to 2025, according to a new research report from Market Research Future (MRFR). A detailed profile of the global drug of abuse testing market is presented in the report, including an analysis of the key players operating in the market, the market’s leading drivers and restraints, and the leading segments holding a dominant share in the market. The past growth trajectory of the global drug of abuse testing market is also examined in detail in the report to enlighten readers as to the likeliest growth trajectory of the market in the forecast period. The global drugs of abuse testing market is expected to rise to a value of more than USD 5 billion by the end of the forecast period in 2025, according to the report.

The growing use of illicit drugs all over the world and the growing awareness about drug of abuse testing are the major drivers for the global drugs of abuse testing market size. Due to the growing number of youths becoming addicted to illegal substances, many governments around the world have come up with strong anti-drugs policies. Strict enforcement of drug monitoring policies is being practiced in most countries around the world. This has led to a growing demand for drugs of abuse testing equipment. This is likely to remain the major driver for the global drug of abuse testing market over the forecast period due to the increasing government efforts to fight growing drug usage.

Competitive Analysis:

Leading players in the global drug of abuse testing market include Quest Diagnostics, Thermo Fisher Scientific Inc., LabCorp, F. Hoffman-La Roche Ltd., Abbott Laboratories, Sonic Healthcare, Randox Laboratories, and Bio-Rad Laboratories Inc.

Segmentation:

The global drug of abuse testing market is segmented on the basis of test type and sample type.

By test type, the global drug of abuse testing market is segmented into laboratory drug testing and onsite screening tests. Onsite screening tests comprise the dominant segment due to the higher convenience and cost-effectiveness of onsite screening. The onsite screening tests segment held a dominant 71.62% share in the market in 2018.

On the basis of sample type, the drug of abuse testing market is segmented into urine, hair, saliva and others. Urine holds a majority share in the global drug of abuse testing market, as urine contains metabolites from several types of drugs. Saliva is the second most popular sample type in the drug of abuse testing market.

Regional Analysis:

The global drug of abuse testing market is segmented by region into North America, Europe, Asia Pacific, and rest of the world.

North America is the dominant revenue generator in the global drug of abuse testing market. The U.S. is the top consumer of drug of abuse testing devices and is likely to retain the position over the forecast period due to the strict enforcement of anti-drug legislation in the country. Awareness among parents about drug use among teenagers is also increasing, which is likely to be a key driver for the drug of abuse testing market in the U.S.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.